Lista de obras - Sarwish Rafiq - Dominio Público Uruguay

CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?

artículo científico publicado en 2015

Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties

artículo científico publicado en 2013

Driving CAR T-cells forward

artículo científico publicado en 2016

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

artículo científico publicado en 2019

Excessive costimulation leads to dysfunction of adoptively transferred T cells

scientific article published on 25 March 2020

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

artículo científico publicado en 2010

Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies

artículo científico publicado en 2013

Hsp90 Co-localizes with Rab-GDI-1 and regulates agonist-induced amylase release in AR42J cells

scientific journal article

Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity

artículo científico publicado en 2014

Inhibition of human erythrocyte invasion by Babesia divergens using serine protease inhibitors

artículo científico publicado en 2007

Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia.

artículo científico publicado en 2018

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

artículo científico publicado en 2014

Optimization of T-cell receptor-modified T cells for cancer therapy

artículo científico publicado en 2020

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.

artículo científico publicado en 2016

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

artículo científico publicado en 2018

Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals

artículo científico publicado en 2012

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

scientific article published on 08 December 2020

Tumors evading CARs-the chase is on

artículo científico publicado en 2018

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells.

artículo científico publicado en 2012

Lista de obras de Sarwish Rafiq

CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?

Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties

Driving CAR T-cells forward

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Excessive costimulation leads to dysfunction of adoptively transferred T cells

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies

Hsp90 Co-localizes with Rab-GDI-1 and regulates agonist-induced amylase release in AR42J cells

Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity

Inhibition of human erythrocyte invasion by Babesia divergens using serine protease inhibitors

Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia.

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

Optimization of T-cell receptor-modified T cells for cancer therapy

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages

Tumors evading CARs-the chase is on

XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cells.